About the Program

Management of Mood Disorders

The Advanced Certificate Program:

Home

Sign In

About

Curriculum

Additional Information

Target Audience

Program Goal

Learning Objectives

CME Information

CME

Contract

Disclosures

Faculty

Roster

Disclosures

Technical Requirements

Update Profile

Contact Us

These independent CME activities are supported by educational grants from

Pfizer Inc.

Additional funding provided by
Projects In Knowledge


Twitter
Keep up to date with us via twitter!

Facebook


Projects In Knowledge
Overlook at Great Notch
150 Clove Road
Little Falls, NJ 07424
Tel: (973) 890-8988
Fax: (973) 890-8866

Projects In Knowledge is pleased to present The Advanced Certificate Program: Management of Mood Disorders, a free CME program for psychiatrists and clinical psychiatrists.
The disease burden of mood disorders goes far beyond clinical sequelae resulting from psychiatric symptoms and associated dysfunction. Medical illnesses associated with depression are well documented across multiple body systems while associations between medical illness and bipolar disorders are still emerging.

Key challenges for busy psychiatrists include improving patients' psychosocial behavior and quality of life, formulating treatment strategies aimed at increasing response rates and remission, and assessing potential pharmacotherapeutic adverse events inherent in complex treatment regimens.

The curriculum offered in this CME program utilizes two landmark NIMH/NIH trials to anchor a comprehensive review of diagnostic methodologies and treatment options for mood disorders, and promises to be a timely and continuously updated source of practical information that clinicians can immediately incorporate into the care and treatment of patients with unipolar major depression and bipolar disorder.

View Curriculum Enroll

Features:
  • Outstanding faculty of psychiatry experts
Chair
Dwight L. Evans
Dwight L. Evans, MD
Ruth Meltzer Professor and Chairman
Professor of Psychiatry, Medicine, and Neuroscience
University of Pennsylvania School of Medicine
Psychiatrist-in-Chief
University of Pennsylvania Health System
Philadelphia, Pennsylvania

 
Faculty
A. John Rush, MD
Professor of Psychiatry and Clinical Sciences
Vice Chair, Department of Clinical Sciences
University of Texas Southwestern Medical Center
Dallas, Texas
Michael E. Thase, MD
Professor of Psychiatry
Director, Mood and Anxiety Disorders
Treatment and Research Program
University of Pennsylvania
Department of Psychiatry
Philadelphia, Pennsylvania
 
  • Timely, clinically focused, and relevant information
  • Convenient web-based curriculum enables self-paced study, 24/7, from home or office
  • Free CME credit provided
  • Complete all courses by December 31, 2008, and receive a certificate of advanced study
  • E-mail notification when a new course becomes available
  • Periodic program updates, news, and announcements
Curriculum Overview:

Depression
  • Biological models for treatment of depression
  • The STAR*D trial: implications for clinical practice
  • Diagnosis and treatment options for patients with depression in the face of co-morbidities
  • Strategies for managing adherence in the patient with mood disorders
  • Emerging treatments for major depressive disorder: is remission possible?
  • Possible relationship between depression and dementia in late life
  • Managing treatment-resistant depression
  • Expert analysis and clinical application of state of the science
Bipolar Disorder
  • Neurobiology of bipolar disorder
  • The STEP-BD trial: assessment of treatment options
  • Differential diagnosis of bipolar disorder I and II
  • Strategies for managing adherence in the bipolar disorder patient
  • Diagnosis and treatment options for patients with bipolar disorder in the face of co-morbidities
  • Emerging treatment options for bipolar disorder
  • Expert analysis and clinical application of state-of-the-science

Learning Objectives:
  • Assess the diagnosis of mood disorders utilizing knowledge of severity of symptoms, duration of symptoms, and functional impairment, in order to determine appropriate treatment approaches.
  • Evaluate the efficacy and safety of antidepressants and other agents used in the treatment of mood disorders as single agents or in combination therapies.
  • Identify strategies designed to improve patient outcomes using novel regimens or combination regimens for the treatment of mood disorders.
Treatment Strategies Discussed

Depression:

  • Maximizing the adequacy of medication treatment
  • Outcomes in outpatients with anxious vs. nonanxious depression
  • Switching antidepressants after first SSRI in Major Depressive Disorder
  • Cognitive therapy vs. medication in augmentation and switch strategies
Bipolar Disorder:
  • Adjunctive bupropion, modafinil, sertraline, and venlafaxine treatment for BP disorder
  • Efficacy of quetiapine monotherapy in bipolar I and II depression
  • Lithium-related and other candidate genes in BP disorder
  • Lamotrigine in the acute treatment of BP depression
  • Psychosocial treatments for BP disorder
Covered Topics Include

STAR*D Trial — Implications for Practice:

  • Complex, real-world patient profiles
  • Managing acute vs. long-term depression
    • Remission vs. relapse
    • Treatment resistance
  • Treatment augmentation and switching therapy
  • The role of cognitive therapy
STEP-BD Trial Results — Implications for Practice:
  • Decipher the bipolar spectrum
  • Understand the controversy of antidepressants
  • Role of antipsychotic therapy
    • Ways to monitor and minimize side effects
  • Management of long-term therapy




Psychiatry News powered by
MedPage Today



















 




ABOUT US  |  CONTACT US  |  CONTRACT  |  DIRECTIONS  |  PRIVACY POLICY  |  RESOURCES  |  1969.02
Copyright © 1997-2010, Projects In Knowledge, Inc. All rights reserved.
PROJECTS IN KNOWLEDGE • Overlook at Great Notch • 150 Clove Road, 10th Floor • Little Falls, New Jersey 07424 (973) 890-8988